Zynext Ventures Invests in Feldan Therapeutics to Drive Innovation in Intracellular Drug Delivery
16 Apr 2025
Pennington, NJ, USA & Québec, Canada – April 16, 2025 – Zynext Ventures USA LLC (Zynext Ventures), the venture capital arm of Zydus Lifesciences (Zydus), today announced its investment in Feldan Therapeutics (Feldan), a Canada-based early clinical-stage pharmaceutical company pioneering the development of treatments based on intracellular delivery of therapeutics.